Details for New Drug Application (NDA): 208135
✉ Email this page to a colleague
NDA 208135 describes TETRACAINE HYDROCHLORIDE, which is a drug marketed by Alcon Labs and Bausch Lomb Ireland and is included in two NDAs. It is available from six suppliers. Additional details are available on the TETRACAINE HYDROCHLORIDE profile page.
The generic ingredient in TETRACAINE HYDROCHLORIDE is tetracaine hydrochloride. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tetracaine hydrochloride profile page.
The generic ingredient in TETRACAINE HYDROCHLORIDE is tetracaine hydrochloride. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tetracaine hydrochloride profile page.
Summary for 208135
| Tradename: | TETRACAINE HYDROCHLORIDE |
| Applicant: | Alcon Labs |
| Ingredient: | tetracaine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 208135
| Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for 208135
Suppliers and Packaging for NDA: 208135
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TETRACAINE HYDROCHLORIDE | tetracaine hydrochloride | SOLUTION;OPHTHALMIC | 208135 | NDA | Alcon Laboratories, Inc. | 0065-0741 | 0065-0741-14 | 12 BLISTER PACK in 1 CARTON (0065-0741-14) / 1 BOTTLE, DROPPER in 1 BLISTER PACK / 4 mL in 1 BOTTLE, DROPPER |
| TETRACAINE HYDROCHLORIDE | tetracaine hydrochloride | SOLUTION;OPHTHALMIC | 208135 | NDA | REMEDYREPACK INC. | 70518-4183 | 70518-4183-0 | 12 BOTTLE, DROPPER in 1 CARTON (70518-4183-0) / 4 mL in 1 BOTTLE, DROPPER (70518-4183-1) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;OPHTHALMIC | Strength | 0.5% | ||||
| Approval Date: | Feb 29, 2016 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
